ELISA F29
In both treatment groups, the number of patients with negative ELISA F29 results increased over the period of observation after the end of nifurtimox treatment. At the 4-year follow-up the proportion of patients with seronegative ELISA F29 values was 77.2% in the 60-day regimen and 66.3% in the 30-day regimen (